Optimization of a gene electrotransfer method for mesenchymal stem cell transfection

Gene Therapy

Volumn 15, Issue 7, 2008, Pages 537-544

  Ferreira, E ^a   Potier, E ^a,b   Logeart Avramoglou, D ^a   Salomskaite Davalgiene, S ^c,d   Mir, L M ^c,e   Petite, H ^a  

^a Paris university   (France)

^b AO RESEARCH INSTITUTE   (Switzerland)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d VYTAUTAS MAGNUS UNIVERSITY   (Lithuania)

^e UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE;

ADIPOSE TISSUE CELL; ANIMAL CELL; ARTICLE; BONE MARROW; CARTILAGE CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL VIABILITY; CONTROLLED STUDY; ELECTRIC FIELD; ELECTROPORATION; ENZYME ACTIVITY; ENZYME SYNTHESIS; GENE EXPRESSION; GENETIC TRANSFECTION; INCUBATION TEMPERATURE; MALE; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPORTER GENE; TISSUE CULTURE; TRANSGENE;

ANIMALS; BETA-GALACTOSIDASE; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; ELECTROPORATION; GENE EXPRESSION; GENE THERAPY; LAC OPERON; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; RATS; RATS, INBRED LEW; TEMPERATURE; TIME FACTORS; TRANSFECTION; TRANSGENES;

RATTUS;

EID: 40949142680     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2008.9     Document Type: Article

References (55)

1. Pereira RF, Halford KW, O'Hara MD, Leeper DB, Sokolov BP, Pollard MD et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci USA 1995; 92: 4957-4861.
2. Pittenger W, Mackay AM, Berk SC, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
3. Bittner RE, Schofer C, Weipoltshammer K, Ivanova S, Streubel B, Hauser E et al. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol (Berl) 1999; 199: 391-396.
4. Murphy JM, Fink DJ, Hunziker EB, Barry FP. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 2003; 48: 3464-3474.
5. Petite H, Viateau V. Bensaid W, Meunier A, de Pollak C, Bourguignon M et al. Tissue-engineered bone regeneration. Nat Biotechnol 2000; 18: 959-963.
6. Orlic D, Kajstura J, Chimenti S, Limana F. Jakoniuk I, Quaini F et al Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Arad Sci USA 2001; 98 10344-10349.
7. Tang YL, Zhao Q, Zhan YC, Cheng L, Liu M, Shi, J, et al. Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept 2004; 117 3-10.
8. Schoeberlein A, Holzgreve W, Dudler L, Hahn S, Surbek DV. Tissue-specific engraftment after in utero transplantation of allogeneic mesenchymal stem cells into sheep fetuses. Am J Obstet Gynecol 2005; 192: 1044-1052.
9. Ryan JM, Barry F, Murphy JM, Mahon BP. Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 2007; 149: 353-363.
10. Jorgensen C, Djouad F, Apparailly F, Noel D. Engineering mesenchymal stem cells for immunotherapy. Gene Therapy 2003; 10:928-931.
11. Meinel L, Hofmann S, Betz O, Fajardo R, Merkle HP, Langer R et al. Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: Comparison of adenovirus mediated gene transfer and protein delivery of BMP-2. Biomaterials 2006; 27: 4993-5002.
12. Vassalli G, Bueler H, Dudler J, von Segesser LK, Kappenberger L. Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardiac and arteries in vivo: A comparative study with adenovirus vectors. Int J Cardiol 2003; 90: 229-238.
13. Kolodka TM, Garlick JA, Taichman LB. Evidence for keratinocyte stem cells in vitro: Long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes. Proc Natl Acad Sci USA 1998; 95:4356-4361.
14. McMahon JM, Conroy S, Lyons M, Greiser U, O'Shea C, Strappe P et al Gene transfer into rat mesenchymal stem cells: A comparative study of viral and nonviral vectors. Stem Cells Dev 2006; 15: 87-96.
15. Chan J, O'Donoghue K, de la Fuente J, Roberts IA, Kumar S, Morgan JE et al. Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells 2005; 23: 93-102.
16. Ito H, Goater JJ, Tiyapatanaputi P, Rubery PT, O'Keefe RJ, Schwarz EM. Light-activated-gene transduction of recombinant adeno-associated virus in human mesenchymal stem cells. Gene Therapy 2004; 11: 34-41.
17. Olmsted-Davis EA, Gugala Z, Gannon FH, Yotnda P, McAlhany RE, Lindsey RW et al. Use of a chimeric adenovirus vector enhances BMP2 production and bone formation. Hum Gene Ther 2002; 13: 1337-1347.
18. Li JZ, Hankins GR, Kao C, Li H, Kammauff J, Helm GA. Osteogenesis in rats induced by a novel recombinant helper-dependent bone morphogenetic protein-9 (BMP-9) adenovirus. J Gene Med 2003; 5: 748-756.
19. Frolova-Jones EA, Ensser A, Stevenson AJ, Kinsey SE, Meredith DM. Stable marker gene transfer into human bone marrow stromal cells and their progenitors using novel herpesvirus saimiri-based vectors. J Hematother Stem Cell Res 2000; 9: 573-581.
20. Hoelter J. Ciccarella M, Drechsel M, Geissler C, Gulkan H, Bocker W et al. Nonviral genetic modification mediates effective transgene expression and functional RNA interferenee in human mesenchymal stem cells. J Gene Med 2005; 7: 718-728.
21. Vanderbyl S, MacDonald GN, Sidhu S, Gung L, Telenius A, Perez C et al Transfer and stable transgene expression of a mammalian artificial chromosome into bone marrow-derived human mesenchymal stem cells. Stem Cells 2004; 22: 324-333.
22. Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1982; 1: 841-845.
23. Potter H, Weir L, Leder P. Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. Proc Natl Acad Sci USA 1984; 81: 7161-7165.
24. Bruggemann U, Roux EC, Hannig J, Nicolau C. Low-oxygen-affinity red cells produced in a large-volume, continuous-flow electroporation system. Transfusion 1995; 35: 478-486.
25. Li LH, Shivakumar R, Feller S, Allen C, Weiss JM, Dzekunov S et al Highly efficient, large volume flow electroporation. Technol Cancer Res Treat 2002; 1: 341-350.
26. Mir LM, Bureau MF, Gehl J, Rangara R, Rouy D, Caillaud JM et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA 1999; 96: 4262-4267.
27. Mir LM. Therapeutic perspectives of in vivo cell electropermeabilization. Bioelectrochemistry 2001; 53: 1-10.
28. Teissie J, Golzio M, Rols MP. Mechanisms of cell membrane electropermeabilization: A minireview of our present (lack of ?) knowledge. Biochim Biophys Acta 2005; 1724: 270-280.
29. Satkauskas S, Bureau MF, Puc M, Mahfoudi A, Scherman D, Miklavcic D et al. Mechanisms of in vivo DNA electrotransfer: Respective contributions of cell electropermeabilization and DNA electrophoresis. Mol Ther 2002; 5: 133-140.
30. Satkauskas S, Andre F, Bureau MF, Scherman D, Miklavcic D, Mir LM. Electrophoretic component of electric pulses determines the efficacy of in vivo DNA electrotransfer. Hum Gene Ther 2005; 16: 1194-1201.
31. Cegovnik U, Novakovic S. Setting optimal parameters for in vitro electrotransfection of B16Fl, SA1, LPB, SCK, L929 and CHO cells using predefined exponentially decaying electric pulses. Bioelectrochemistry 2004; 62: 73-82.
32. Pucihar G, Mir LM, Miklavcic D. The effect of pulse repetition frequency on the uptake into electtopermeabilized cells in vitro with possible applications in electrochemotherapy. Bioelectrochemistry 2002; 57: 167-172.
33. Puc M, Flisar K, Rebersek S, Miklavcic D. Electroporator for in vitro cell permeabilization. Radiol Oncol 2001; 35: 203-207.
34. Peister A, Mellad JA, Wang M, Tucker HA, Prockop DJ. Stable transfection of MSCs by electroporation. Gene Therapy 2004; 11: 224-228.
35. Bureau MF, Gehl J, Deleuze V, Mir LM, Scherman D. Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. Biochim Biophys Acta 2000; 1474: 353-359.
36. Pucihar G, Kotnik T, Kanduser M, Miklavcic D. The influence of medium conductivity on electropermeabilization and survival of cells in vitro. Bioelectrochemistry 2001; 54: 107-115.
37. Rols MP, Delteil C, Serin G, Teissie J. Temperature effects on electrotransfection of mammalian cells. Nucleic Acids Res 1994; 22: 540.
38. Golzio M, Rols MP, Teissie J. In vitro and in vivo electric field-mediated permeabilization, gene transfer, and expression. Methods 2004; 33: 126-135.
39. Teissie J, Eynard N, Gabriel B, Rols UP. Electropermeabilization of cell membranes. Adv Drug Deliv Rev 1999; 35: 3-19.
40. Kotnik T, Mir LM, Flisar K, Puc M, Miklavcic D. Cell membrane electropermeabilization by symmetrical bipolar rectangular pulses. Part I. Increased efficiency of permeabilization. Bioelectrochemistry 2001; 54: 83-90.
41. Puc M, Kotnik T, Mir LM, Miklavcic D. Quantitative model of small molecules uptake after in vitro cell electropermeabilization. Bioelectrochemistry 2003; 60: 1-10.
42. Mohr JC, de Pablo JJ, Palecek SP. Electroporation of human embryonic stem cells: Small and macromolecule loading and DNA transfection. Biotechnol Prog 2006; 22: 825-834.
43. Matthews KE, Dev SB, Toneguzzo F, Keating A. Electroporation for gene therapy. Methods Mol Biol 1995; 48: 273-280.
44. Hilgendorf C, Spahn-Langguth H, Rhedin M, Regardh CG, Lowenadler B, Langguth P. Selective downregulation of the MDR1 gene product in Caco-2 cells by stable transfection to prove its relevance in secretory drug transport. Mol Pharm 2005; 2: 64-73.
45. Girod PA, Nguyen DQ, Calabrese D, Puttini S, Grandjean M, Martinet D et al. Genome-wide prediction of matrix attachment regions that increase gene expression in mammalian cells. Nat Methods 2007; 4: 747-753.
46. Chen ZY, He CY, Ehrhardt A, Kay MA. Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level-transgene expression in vivo. Mol Ther 2003; 8: 495-500.
47. Gresch O, Engel FB, Nesic D, Tran TT, England HM, Hickman ES et al New non-Viral method for gene transfer into primary cells. Methods 2004; 33: 151-163.
48. Potapova I, Plotnikov A, Lu Z, Danilo Jr P, Valiunas V, Qu J et al Human mesenchymal stem cells'as a gene delivery system to create cardiac pacemakers. Circ Res 2004; 94: 952-959.
49. Plotnikov AN, Shlapakova I, Szabolcs MJ, Danilo Jr P, Lorell BH, Potapova IA et al. Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heart. Circulation 2007; 116: 706-713.
50. Chen TH, Chen WM, Hsu KH, Kuo CD, Hung SC. Sodium butyrate activates ERK to regulate differentiation of mesenchymal stem cells. Biochem Biophys Res Commun 2007; 355: 913-918.
51. Aluigi M, Fogli M, Curti A, Isidori A, Gruppioni E, Chiodoni C et al Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cells. Stem Cells 2006; 24: 454-461.
52. Aslan H, Zilberman Y, Arbeli V, Sheyn D, Matan Y, Liebergall M et al Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration. Tissue Eng 2006; 12: 877-889.
53. Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007; 25: 1384-1392.
54. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970; 3: 393-403.
55. Kotnik T, Pucihar G, Rebersek M, Miklavcic D, Mir LM. Role of pulse shape in cell membrane electropermeabilization. Biochim Biophys Acta 2003; 1614: 193-200.